Response to: 'Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia' by Morton and Thompson

BMJ Qual Saf. 2019 Mar;28(3):255-256. doi: 10.1136/bmjqs-2018-009213. Epub 2019 Jan 3.
No abstract available

Keywords: health services research; hospital medicine; quality measurement.

Publication types

  • Letter
  • Comment

MeSH terms

  • Australia
  • Hospitals, Public
  • Humans
  • Melanoma*
  • Prevalence
  • Sentinel Lymph Node Biopsy*